• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

Time to antithrombotic therapy after transient ischaemic attack and ischaemic stroke
Med J Aust. 2022 May 11. doi: 10.5694/mja2.51532. Online ahead of print.NO ABSTRACTPMID:35546263 | DOI:10.5694/mja2.51532
Source: Medical Journal of Australia - May 13, 2022 Category: General Medicine Authors: Thanh G Phan Benjamin Clissold Henry Ma Source Type: research

Persistent pathology of the patent foramen ovale: a review of the literature
Med J Aust. 2021 Jul 4. doi: 10.5694/mja2.51141. Online ahead of print.ABSTRACTA patent foramen ovale (PFO) is an interatrial shunt, with a prevalence of 20-34% in the general population. While most people do not have secondary manifestations of a PFO, some reported sequelae include ischaemic stroke, migraine, platypnoea-orthodeoxia syndrome and decompression illness. Furthermore, in some cases, PFO closure should be considered for patients before neurosurgery and for patients with concomitant carcinoid syndrome. Recent trials support PFO closure for ischaemic stroke patients with high risk PFOs and absence of other identi...
Source: Medical Journal of Australia - July 4, 2021 Category: General Medicine Authors: Kenneth K Cho Shaun Khanna Phillip Lo Daniel Cheng David Roy Source Type: research

Improving acute stroke care in regional hospitals: clinical evaluation of the Victorian Stroke Telemedicine program.
CONCLUSIONS: Telemedicine has provided Victorian regional hospitals access to expert care for emergency department patients with suspected acute stroke. Eligible patients with ischaemic stroke are now receiving stroke thrombolysis more quickly and safely. PMID: 32255520 [PubMed - as supplied by publisher]
Source: Medical Journal of Australia - April 8, 2020 Category: General Medicine Tags: Med J Aust Source Type: research

Advances in stroke medicine.
Authors: Campbell BC Abstract In recent years, reperfusion therapies such as intravenous thrombolysis and endovascular thrombectomy for ischaemic stroke have dramatically reduced disability and revolutionised stroke management. Thrombolysis with alteplase is effective when administered to patients with potentially disabling stroke, who are not at high risk of bleeding, within 4.5 hours of the time the patient was last known to be well. Emerging evidence suggests that other thrombolytics such as tenecteplase may be even more effective. Treatment may be possible beyond 4.5 hours in patients selected using brain imagi...
Source: Medical Journal of Australia - May 6, 2019 Category: General Medicine Tags: Med J Aust Source Type: research

Risk-adjusted hospital mortality rates for stroke: evidence from the Australian Stroke Clinical Registry (AuSCR).
CONCLUSIONS: Hospital stroke mortality rates and hospital performance ranking may vary widely according to the covariates included in the statistical analysis. PMID: 28446116 [PubMed - in process]
Source: Medical Journal of Australia - April 29, 2017 Category: Journals (General) Tags: Med J Aust Source Type: research